ARTH   $6.4  -16.67% Market Closed

Arch Therapeutics Inc
Total Cash 30.03K
totalCashPerShare 0.007
EBITDA -4.72M
Total Debt 9.39M
quickRatio 0.002
currentRatio 0.1
Total Revenue 148.16K
debtToEquity
Revenue/Share 0.027
ROA -1.9927299
ROE
grossProfits
freeCashflow -3.72M
operatingCashflow -3.70M
earningsGrowth
revenueGrowth 1.326
grossMargins 0.39578998
ebitdaMargins 0.0
operatingMargins -33.043568
profitMargins 0.0
enterpriseValue 10.56M
forwardPE
floatShares 4.30M
sharesOutstanding 4.44M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.04%
heldPercentInstitutions 0.03%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue -2.826
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -12.99M
trailingEps -1.01%
forwardEps 10.39%
enterpriseToEbitda -2.24
lastDividendValue
lastDividendDate
currentQuarterEstimate 4Q 2023
institutionsCount 5
lastUpdated Oct. 16, 2024, 12:46 p.m.